Search > Alzheimer's Disease
210 Participants NeededMy employer runs this trial

ML-007C-MA for Alzheimer's Disease Psychosis

Recruiting at 1 trial location
CT
Overseen ByClinical Trials Contact Center
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: MapLight Therapeutics
Must be taking: ML-007C-MA
Must not be taking: Protocol-defined prohibited medications
Disqualifiers: Hospice care, Suicidal risk, others
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

ML-007C-MA-222 is a 52-week, flexible-dose, open-label extension study designed to evaluate the long-term safety, tolerability, and effectiveness of ML007C-MA in participants with ADP who have completed the antecedent study (ie, Study ML-007C-MA-221).

Who Is on the Research Team?

MT

MapLight Therapeutics

Principal Investigator

MapLight Therapeutics

Are You a Good Fit for This Trial?

Inclusion Criteria

I am willing and able to give written consent to join the study.
Has completed the Double-Blind Treatment Period of an antecedent study with ML-007C-MA
My condition may improve with long-term ML-007C-MA treatment.
See 2 more

Exclusion Criteria

Has an elevated risk of suicidal behavior
Has developed an allergy or other intolerance to ML-007C-MA, its active ingredients, or their excipients
Requires treatment with protocol-defined prohibited medications
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Open-label extension

Participants receive ML007C-MA to evaluate long-term safety, tolerability, and effectiveness

52 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • ML-007C-MA

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ML-007C-MAExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

MapLight Therapeutics

Lead Sponsor

Trials
3
Recruited
570+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.